FDA Inspection 930565 — Maxigen Biotech, Inc.
The FDA completed an inspection of Maxigen Biotech, Inc. on May 21, 2015 in Taoyuan City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Devices.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- May 21, 2015
- Fiscal Year
- 2015
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Taoyuan City (Taiwan)